讯飞医疗科技股份有限公司是一家主要从事提供人工智能赋能的医疗解决方案的中国公司。基层医疗服 务业务线由智医助理及慢病管理组成。医院服务业务线包括智慧医院解决方案和诊疗助理。患者服务业 务线包括智慧医院患者服务与诊后管理（包括讯飞晓医App及小程序）、影像云平台以及医疗器械。区 域管理平台解决方案业务线包括智慧卫生解决方案和智慧医保。该公司主要在国内市场开展业务。 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成 投资建议。 证券之星消息，2月27日南向资金增持2.6万股讯飞医疗科技（02506.HK）。近5个交易日中，获南向资 金增持的有3天，累计净增持9.85万股。近20个交易日中，获南向资金增持的有11天，累计净增持12.06 万股。截至目前，南向资金持有讯飞医疗科技（02506.HK）523.32万股，占公司已发行普通股的 6.76%。 ...

以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成 投资建议。 讯飞医疗科技股份有限公司是一家主要从事提供人工智能赋能的医疗解决方案的中国公司。基层医疗服 务业务线由智医助理及慢病管理组成。医院服务业务线包括智慧医院解决方案和诊疗助理。患者服务业 务线包括智慧医院患者服务与诊后管理（包括讯飞晓医App及小程序）、影像云平台以及医疗器械。区 域管理平台解决方案业务线包括智慧卫生解决方案和智慧医保。该公司主要在国内市场开展业务。 证券之星消息，2月26日南向资金减持4000.0股讯飞医疗科技（02506.HK）。近5个交易日中，获南向资 金增持的有3天，累计净增持8.58万股。近20个交易日中，获南向资金增持的有10天，累计净增持5.79万 股。截至目前，南向资金持有讯飞医疗科技（02506.HK）520.72万股，占公司已发行普通股的6.73%。 ...

Core Viewpoint - Southbound funds increased their holdings in iFlytek Medical Technology (02506.HK) by 13,400 shares on February 12, indicating a fluctuating interest from investors in the company [1] Group 1: Southbound Fund Activity - Over the past five trading days, there were three days of net reductions in holdings, totaling a decrease of 227,900 shares [1] - In the last twenty trading days, there were ten days of net increases, with a total increase of 326,000 shares [1] - As of now, southbound funds hold 5,134,800 shares of iFlytek Medical Technology, representing 6.63% of the company's total issued ordinary shares [1] Group 2: Company Overview - iFlytek Medical Technology Co., Ltd. primarily provides AI-enabled medical solutions in China [1] - The company's business lines include grassroots medical services (comprising intelligent medical assistants and chronic disease management), hospital services (including smart hospital solutions and diagnostic assistants), and patient services (such as smart hospital patient services and post-discharge management) [1] - The regional management platform solutions business line includes smart health solutions and smart medical insurance [1]

Group 1 - The core point of the article highlights that southbound funds have reduced their holdings in iFlytek Medical Technology (02506.HK) by 186,500 shares on February 10, 2026, marking a decrease of 3.44% [1][2] - Over the past five trading days, there have been four days of reductions in holdings, totaling a net decrease of 210,700 shares [1] - In the last 20 trading days, there were 11 days of increased holdings, with a cumulative net increase of 1,308,000 shares [1] Group 2 - As of now, southbound funds hold 5,231,600 shares of iFlytek Medical Technology, which represents 6.76% of the company's total issued ordinary shares [1] - The company primarily engages in providing AI-powered medical solutions, with business lines including grassroots medical services, hospital services, patient services, and regional management platform solutions [2] - The grassroots medical services line consists of intelligent medical assistants and chronic disease management, while the hospital services line includes smart hospital solutions and diagnostic assistance [2]

Core Viewpoint - The southbound capital has increased its holdings in iFlytek Medical Technology (02506.HK), indicating growing investor interest in the company, particularly in the context of its AI-enabled healthcare solutions [1][2]. Group 1: Shareholding Changes - On February 6, 2026, southbound capital increased its holdings by 75,200 shares, representing a 1.40% increase [2]. - Over the past five trading days, there were two days of net increases, totaling 140,300 shares [1]. - In the last 20 trading days, there were 12 days of net increases, amounting to 1,661,200 shares [1]. Group 2: Current Shareholding Status - As of February 6, 2026, southbound capital holds 5,437,800 shares of iFlytek Medical Technology, which accounts for 7.02% of the company's total issued ordinary shares [1][2]. Group 3: Company Overview - iFlytek Medical Technology is primarily engaged in providing AI-enabled healthcare solutions in China, with business lines including grassroots medical services, hospital services, patient services, and regional management platform solutions [2].

Core Viewpoint - Southbound funds reduced their holdings in iFlytek Medical Technology (02506.HK) by 9,400 shares on February 5, indicating a potential shift in investor sentiment towards the company [1] Group 1: Southbound Fund Activity - Over the past 5 trading days, there were 2 days of net purchases by southbound funds, totaling an increase of 104,500 shares [1] - In the last 20 trading days, there were 12 days of net purchases, with a cumulative increase of 1,634,000 shares [1] - Currently, southbound funds hold 5,362,600 shares of iFlytek Medical Technology, representing 6.93% of the company's total issued ordinary shares [1] Group 2: Company Overview - iFlytek Medical Technology Co., Ltd. primarily provides AI-enabled medical solutions in China [1] - The company's business lines include grassroots medical services (intelligent medical assistants and chronic disease management), hospital services (smart hospital solutions and diagnostic assistants), and patient services (smart hospital patient services and post-discharge management, including the iFlytek Xiaoyi App and mini-programs) [1] - The regional management platform solutions business line encompasses smart health solutions and smart medical insurance [1] - The company mainly operates in the domestic market [1]

Core Viewpoint - The article highlights the increasing investment interest from southbound funds in iFlytek Medical Technology (02506.HK), indicating a positive trend in stock accumulation over recent trading days [1]. Group 1: Investment Activity - On February 2, southbound funds increased their holdings by 194,000 shares in iFlytek Medical Technology [1]. - Over the past five trading days, there were four days of net increases, totaling 319,300 shares [1]. - In the last twenty trading days, there were twelve days of net increases, amounting to 1,632,800 shares [1]. - As of now, southbound funds hold 5,491,500 shares of iFlytek Medical Technology, representing 7.1% of the company's total issued ordinary shares [1]. Group 2: Company Overview - iFlytek Medical Technology Co., Ltd. primarily provides AI-enabled medical solutions in China [2]. - The company's business lines include grassroots medical services, hospital services, patient services, and regional management platform solutions [2]. - Grassroots medical services consist of intelligent medical assistants and chronic disease management [2]. - Hospital services include smart hospital solutions and diagnostic assistance [2]. - Patient services encompass smart hospital patient services, post-discharge management, imaging cloud platforms, and medical devices [2]. - Regional management platform solutions involve smart health solutions and smart medical insurance [2].

证券之星消息，1月29日南向资金增持4.57万股讯飞医疗科技（02506.HK）。近5个交易日中，获南向资 金增持的有4天，累计净增持14.55万股。近20个交易日中，获南向资金增持的有11天，累计净增持 133.56万股。截至目前，南向资金持有讯飞医疗科技（02506.HK）525.82万股，占公司已发行普通股的 6.79%。 讯飞医疗科技股份有限公司是一家主要从事提供人工智能赋能的医疗解决方案的中国公司。基层医疗服 务业务线由智医助理及慢病管理组成。医院服务业务线包括智慧医院解决方案和诊疗助理。患者服务业 务线包括智慧医院患者服务与诊后管理（包括讯飞晓医App及小程序）、影像云平台以及医疗器械。区 域管理平台解决方案业务线包括智慧卫生解决方案和智慧医保。该公司主要在国内市场开展业务。 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成 投资建议。 ...

Core Viewpoint - The southbound capital has increased its holdings in iFlytek Medical Technology (02506.HK), indicating growing investor interest in the company [1]. Group 1: Shareholding Changes - On January 23, 2026, southbound capital held a total of 5.1505 million shares of iFlytek Medical Technology, with an increase of 37,900 shares, representing a change of 0.74% [2]. - Over the past five trading days, there were two days of net increases in holdings, totaling 36,900 shares [1]. - In the last 20 trading days, there were eight days of net increases, accumulating to 1.1123 million shares [1]. Group 2: Company Overview - iFlytek Medical Technology is primarily engaged in providing AI-powered medical solutions in China, with business lines including grassroots medical services, hospital services, patient services, and regional management platform solutions [2]. - The grassroots medical services include intelligent medical assistants and chronic disease management [2]. - The hospital services encompass smart hospital solutions and diagnostic assistance, while patient services involve smart hospital patient services and post-discharge management [2].

Group 1 - The core point of the article highlights that southbound funds have reduced their holdings in iFlytek Medical Technology (02506.HK) by 3,500 shares on January 8, with a total net reduction of 193,900 shares over the last five trading days [1] - Over the past 20 trading days, there have been 11 days of net reductions in southbound fund holdings, totaling 215,500 shares [1] - As of now, southbound funds hold 3,728,700 shares of iFlytek Medical Technology, which represents 4.82% of the company's total issued ordinary shares [1] Group 2 - iFlytek Medical Technology Co., Ltd. primarily provides AI-enabled medical solutions in China [1] - The company's business lines include grassroots medical services, hospital services, patient services, and regional management platform solutions [1] - The grassroots medical services line consists of intelligent medical assistants and chronic disease management, while the hospital services line includes smart hospital solutions and diagnostic assistance [1]